Streetbeat News

Revenues

ATUS

Altice USA (NYSE:ATUS) reported Q2 earnings of $0.03 per share, missing the analyst estimate of $0.07 by 57.14%. Sales were $2.24 billion, also missing the $2.26 billion estimate. Both earnings and sales showed declines compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:08 am

APPN

Appian Corporation (APPN) reported its Q2 2024 financial results, with an adjusted EPS of $(0.26), beating the estimate of $(0.31). The company also reported sales of $146.450 million, surpassing the expected $142.954 million.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:08 am

WW

WW International has revised its FY24 revenue forecast downwards from $830M-$860M to at least $770M, below the estimated $841.835M. The company expects an operating loss of up to $180.7M, but adjusted operating income, excluding certain charges, is projected to be at least $100M.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:07 am

ICLN

TSM

Researchers have identified a 'Trump Dump' effect, where former President Donald Trump's public criticisms lead to significant stock market declines in targeted companies and sectors. Notable impacts include a 17% drop in Taiwan Semiconductor (TSM) and a 10% decline in the iShares Global Clean Energy ETF (ICLN). The phenomenon raises concerns about potential market instability if Trump wins a second term.

Portfolio Pulse from Navdeep Yadav

August 01, 2024 | 11:07 am

TRN

Trinity Industries has raised its 2024 guidance, now expecting EPS of $1.55 to $1.75, up from the prior $1.35 to $1.55, and above the $1.51 estimate. The company also anticipates industry deliveries of approximately 40,000 railcars.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:07 am

CRTO

Criteo reported Q2 adjusted EPS of $0.46 and sales of $267.09 million, both beating estimates.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:07 am

NVRI

Enviri (NYSE:NVRI) reported Q2 2024 adjusted EPS of $0.02, beating the $(0.01) estimate, but missed sales estimates with $610 million versus $616.9 million expected. Sales increased by 17.27% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:07 am

NBIX

Neurocrine Biosciences has raised its FY24 net product sales guidance for INGREZZA to a range of $2.25 billion to $2.3 billion. The company also updated its expense guidance for R&D and SG&A expenses.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:06 am

OWL

Blue Owl Capital (NYSE: OWL) reported Q2 2024 adjusted EPS of $0.19, meeting analyst expectations. The company also reported sales of $549.848 million, surpassing the $505.850 million estimate by 8.70% and marking a 31.88% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:06 am

BIGC

BigCommerce Holdings reported Q2 2024 adjusted EPS of $0.05, beating the estimate of $0.03. Sales were $81.829 million, surpassing the $81.084 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:06 am